This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Functional Endoscopic Sinus Surgery (FESS)
and you are
between 18 and 60
years old
This is a trial in the final phase before the treatment is released on the market.
Show me locations

The purpose

Postoperative analgesia after FESS can be achieved through opioids, NSAIDs, topical or infiltration of local anaesthetic and regional techniques like sphenopalatine ganglion (SPG) block, infraorbital nerve block and nasociliary block. As the current evidences regarding the benefit of SPG block after FESS is controversial, efficacy of sphenopalatine ganglion block will be evaluated using bupivacaine or ropivacaine as local anaesthetic in adult patients undergoing FESS under general anaesthesia in this study.

Provided treatments

  • Drug: Bupivacaine
  • Drug: Ropivacaine
  • Other: Normal Saline

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03013361. The sponsor of the trial is Postgraduate Institute of Medical Education and Research and it is looking for 60 volunteers for the current phase.
Official trial title:
Comparison Ropivacaine and Bupivacaine in Sphenopalatine Ganglion Block for Postoperative Analgesia After Functional Endoscopic Sinus Surgery: A Randomized Controlled Trial